To verify our hypothesis, we first conducted a TOP/FOPFlash reporter assay in ASPM KD and control HCC cells and found that deletion of ASPM significantly inhibited the transcription activity of β‐catenin/TCF4 in both HepG2 and SMMC7721 cells (Fig. 5A). The gene discussed is TCF4; the disease is hepatocellular carcinoma.